Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Integrated BioPharma Inc News

    0,1806 $ -21,34% -0,049 $
    In : 0,1684 € | 09.04.24 15:30:00 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 120093
    ISIN: US45811V1052
    US-Symbol: INBP
    Typ: Aktie

    Integrated BioPharma Inc News

    13.09.22 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022
    HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ...
    21.06.22 - ACCESSWIRE
    Integrated BioPharma Announces Change in Directors
    HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I ...
    12.05.22 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
    HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, ...
    10.02.22 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021
    HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December ...
    10.11.21 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021
    HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended ...
    02.09.21 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
    HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ...
    13.05.21 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
    HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2021.
    15.04.21 - PR Newswire
    OTC Markets Group Announces Quarterly Index Performance and Rebalancing
    OTC Markets Group Announces Quarterly Index Performance and Rebalancing PR Newswire
    08.04.21 - ACCESSWIRE
    Integrated BioPharma Announces Launch of Investors Website
    Integrated BioPharma Announces Launch of Investors Website
    12.02.21 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended December 31, 2020
    HILLSIDE, NJ / ACCESSWIRE / February 12, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended ...
    22.01.21 - PR Newswire
    OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX
    OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX PR Newswire
    22.01.21 - ACCESSWIRE
    Integrated BioPharma Announces Upgrade to OTCQX
    HILLSIDE, NJ / ACCESSWIRE / January 22, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP"), upgraded to the OTCQX® Best Market from OTCQB® ...
    12.11.20 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended September 30, 2020
    HILLSIDE, NJ / ACCESSWIRE / November 12, 2020 / Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended ...
    23.09.20 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2020
    HILLSIDE, NJ / ACCESSWIRE / September 23, 2020 / Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company" or "INBP") reports its financial results for the fiscal year ended June ...
    13.05.20 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended March 31, 2020
    HILLSIDE, NJ / ACCESSWIRE / May 13, 2020 / Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company") reports its financial results for the quarter ended March 31, 2020.
    12.02.20 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended December 31, 2019
    HILLSIDE, NJ / ACCESSWIRE / February 12, 2020 / Integrated BioPharma, Inc. (OTC BB:INBP) (the "Company") reports its financial results for the quarter ended December 31, 2019.
    13.11.19 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended September 30, 2019
    HILLSIDE, NJ / ACCESSWIRE / November 13, 2019 / Integrated BioPharma, Inc. (OTC BB:INBP) (the "Company") reports it financial results for the quarter ended September 30, 2019.
    16.09.19 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2019
    HILLSIDE, NJ / ACCESSWIRE / September 16, 2019 / Integrated BioPharma, Inc. (OTCQB:INBP) (the “Company” or “INBP”) reported financial results for the fiscal year ended June 30, ...
    15.05.19 - ACCESSWIRE
    Integrated BioPharma Reports Results for its Quarter Ended March 31, 2019 and Announces Refinancing of its Senior Credit Facility with PNC Bank, National Association
    HILLSIDE, NJ / ACCESSWIRE / May 15, 2019 / Integrated BioPharma, Inc. (OTCQB: INBP) (the "Company" or "INBP") reported financial results today for the three and nine-​month ...
    06.05.19 - ACCESSWIRE
    Integrated BioPharma Names Christina Kay and Riva Sheppard as Co-Chief Executive Officers
    HILLSIDE, NJ / ACCESSWIRE / May 6, 2019 / Integrated BioPharma, Inc. (OTCQB: INBP) (the "Company" or "INBP") announced today that its Board of Directors (the "Board") has ...

    Newssuche

    Videos

    newspaper
    09:30 Uhr +17,89%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »